SL
SLN

Siren LLC’s Silence Therapeutics SLN Stock Holding History

Siren LLC’s Portfolio SLN Stock Details SLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.4M Buy
3,311,438
+400,000
+14% +$2.81M 0.74% 36
2026
Q1 		$15.3M Hold
2,911,438
– – 0.43% 51
2025
Q4 		$17.7M Hold
2,911,438
– – 0.53% 40
2025
Q3 		$15.1M Hold
2,911,438
– – 0.59% 39
2025
Q2 		$16.9M Buy
2,911,438
+121,605
+4% +$521K 0.87% 32
2025
Q1 		$7.87M Sell
2,789,833
-41,937
-1% -$205K 0.44% 44
2024
Q4 		$19.5M Hold
2,831,770
– – 0.86% 33
2024
Q3 		$51.5M Buy
+2,831,770
New +$52.7M 2.57% 13

Other funds holding SLN

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

Siren LLC's SLN Position: Q2 2026 in Review

Siren LLC increased its Silence Therapeutics (SLN) stake by 14% in Q2 2026, buying an estimated $2.81M and bringing the position to 3,311,438 shares worth $36.4M. The position accounts for 0.74% of the portfolio, ranked #36.

Siren LLC first reported a position in SLN in Q3 2024 and has held it in 8 quarters since. The position peaked at $51.5M in Q3 2024. 72 funds tracked by Wall St. Rank hold SLN as of Q2 2026.

  • Siren LLC held 3,311,438 shares of Silence Therapeutics worth $36.4M as of Q2 2026.
  • Siren LLC bought 400,000 Silence Therapeutics shares in Q2 2026, an estimated $2.81M.
  • Silence Therapeutics made up 0.74% of Siren LLC's portfolio in Q2 2026, its #36 holding.
  • Siren LLC first reported a position in Silence Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Siren LLC's Silence Therapeutics position peaked at $51.5M in Q3 2024.
  • 72 funds tracked by Wall St. Rank held Silence Therapeutics as of Q2 2026.

Based on Siren LLC's 13F filing for Q2 2026, filed 13 Aug 2026.